Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT03531918 |
Title | Gemtuzumab Ozogamicin With G-CSF, Cladribine, Cytarabine and Mitoxantrone in Treating Participants With Previously Untreated Acute Myeloid Leukemia or High-Grade Myeloid Neoplasm |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Fred Hutchinson Cancer Research Center |
Indications | |
Therapies |
Cladribine + Cytarabine + Filgrastim + Gemtuzumab ozogamicin + Mitoxantrone |
Age Groups: | adult | senior |
Covered Countries | USA |